These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29785620)

  • 1. How asymptomatic are early cancer patients of five organs based on registry data in Japan.
    Nakabayashi N; Hirose M; Suzuki R; Suzumiya J; Igawa M
    Int J Clin Oncol; 2018 Oct; 23(5):999-1006. PubMed ID: 29785620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan.
    Fujiwara M; Inagaki M; Nakaya N; Fujimori M; Higuchi Y; Hayashibara C; So R; Kakeda K; Kodama M; Uchitomi Y; Yamada N
    Psychiatry Clin Neurosci; 2017 Dec; 71(12):813-825. PubMed ID: 28875514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in clinical stage distribution and screening detection of cancer in Osaka, Japan: Stomach, colorectum, lung, breast and cervix.
    Toyoda Y; Tabuchi T; Hama H; Morishima T; Miyashiro I
    PLoS One; 2020; 15(12):e0244644. PubMed ID: 33382821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparities in stage at diagnosis for five common cancers in China: a multicentre, hospital-based, observational study.
    Zeng H; Ran X; An L; Zheng R; Zhang S; Ji JS; Zhang Y; Chen W; Wei W; He J;
    Lancet Public Health; 2021 Dec; 6(12):e877-e887. PubMed ID: 34838194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Socioeconomic Status Assessed by Areal Deprivation With Cancer Incidence and Detection by Screening in Miyagi, Japan Between 2005 and 2010.
    Kaneko N; Nishino Y; Ito Y; Nakaya T; Kanemura S
    J Epidemiol; 2023 Oct; 33(10):521-530. PubMed ID: 35851564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study.
    Sato A; Matsubayashi K; Morishima T; Nakata K; Kawakami K; Miyashiro I
    BMC Cancer; 2021 Mar; 21(1):264. PubMed ID: 33691661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Difference of stage at cancer diagnosis by socioeconomic status for four target cancers of the National Cancer Screening Program in Korea: Results from the Gwangju and Jeonnam cancer registries.
    Kweon SS; Kim MG; Kang MR; Shin MH; Choi JS
    J Epidemiol; 2017 Jul; 27(7):299-304. PubMed ID: 28279589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Report of Cancer Incidence and Mortality in China, 2014].
    Chen WQ; Li H; Sun KX; Zheng RS; Zhang SW; Zeng HM; Zou XN; Gu XY; He J
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):5-13. PubMed ID: 29365411
    [No Abstract]   [Full Text] [Related]  

  • 9. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
    Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer screening status in Korea, 2011: results from the Korean National Cancer Screening Survey.
    Park B; Choi KS; Lee YY; Jun JK; Seo HG
    Asian Pac J Cancer Prev; 2012; 13(4):1187-91. PubMed ID: 22799303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer in Canada: Stage at diagnosis.
    Bryan S; Masoud H; Weir HK; Woods R; Lockwood G; Smith L; Brierley J; Gospodarowicz M; Badets N
    Health Rep; 2018 Dec; 29(12):21-25. PubMed ID: 30566206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site-specific patterns of early-stage cancer diagnosis during the COVID-19 pandemic.
    Kinslow CJ; DeStephano DM; Neugut AI; Taparra K; Horowitz DP; Yu JB; Cheng SK
    JNCI Cancer Spectr; 2024 Apr; 8(3):. PubMed ID: 38521544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diffusion of screening programmes in Italy, year 2009.
    Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
    Epidemiol Prev; 2011; 35(5-6 Suppl 5):3-7. PubMed ID: 22166346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
    Machii R; Takahashi H
    Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer screening in the primary care setting: the role of the primary care physician in screening for breast, cervical, colorectal, lung, ovarian, and prostate cancers.
    Miser WF
    Prim Care; 2007 Mar; 34(1):137-67. PubMed ID: 17481991
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of cervical cancer screening based on a mathematical screening model using data from the Hiroshima Prefecture Cancer Registry.
    Ito K; Tsunematsu M; Satoh K; Kakehashi M; Nagata Y
    Asian Pac J Cancer Prev; 2013; 14(8):4897-902. PubMed ID: 24083688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying incident colorectal and lung cancer cases in health service utilisation databases in Australia: a validation study.
    Goldsbury D; Weber M; Yap S; Banks E; O'Connell DL; Canfell K
    BMC Med Inform Decis Mak; 2017 Feb; 17(1):23. PubMed ID: 28241763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A report of five cancer screening rates and the related measures for cancer control in the workplace, surveyed by the Corporate Action to Promote Cancer Control].
    Minamitani M; Mukai T; Tatemichi M; Katano A; Fukuyoshi J; Nakagawa K
    Sangyo Eiseigaku Zasshi; 2023 Sep; 65(5):231-247. PubMed ID: 36967124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.